Medical System Network Co., Ltd. (TYO:4350)
Japan · Delayed Price · Currency is JPY 486.00
+7.00 (1.46%)
Aug 21, 2026, 3:30 PM JST
Medical System Network Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 134,233 | 132,186 | 122,387 | 115,361 | 109,551 | 106,685 | |
Revenue Growth | 8.19% | 8.01% | 6.09% | 5.30% | 2.69% | 2.33% |
Cost of Revenue | 80,205 | 78,440 | 71,651 | 67,435 | 63,629 | 62,256 |
Gross Profit | 54,028 | 53,746 | 50,736 | 47,926 | 45,922 | 44,429 |
Selling, General & Admin | 43,492 | 42,895 | 40,555 | 37,448 | 36,511 | 34,508 |
Other Operating Expenses | 7,537 | 7,537 | 7,027 | 6,645 | 6,247 | 6,068 |
Operating Expenses | 51,029 | 50,432 | 47,582 | 44,093 | 42,758 | 40,576 |
Operating Income | 2,999 | 3,314 | 3,154 | 3,833 | 3,164 | 3,853 |
Interest Expense | -380 | -343 | -278 | -288 | -277 | -183 |
Interest & Investment Income | 14 | 14 | 7 | 4 | 5 | 6 |
Earnings From Equity Investments | -93 | -84 | - | - | - | - |
Other Non Operating Income (Expenses) | 330 | 290 | 277 | 274 | 462 | 638 |
EBT Excluding Unusual Items | 2,870 | 3,191 | 3,160 | 3,823 | 3,354 | 4,314 |
Gain (Loss) on Sale of Investments | - | - | - | 78 | - | 112 |
Gain (Loss) on Sale of Assets | -3 | 11 | 332 | 13 | 7 | -9 |
Asset Writedown | -565 | -564 | -767 | -445 | -304 | -411 |
Other Unusual Items | -88 | -88 | -2 | -20 | -39 | 7 |
Pretax Income | 2,216 | 2,550 | 2,723 | 3,449 | 3,018 | 4,013 |
Income Tax Expense | 1,309 | 1,437 | 1,424 | 1,579 | 1,389 | 1,624 |
Earnings From Continuing Operations | 907 | 1,113 | 1,299 | 1,870 | 1,629 | 2,389 |
Minority Interest in Earnings | -39 | -43 | -37 | -10 | -19 | 5 |
Net Income | 868 | 1,070 | 1,262 | 1,860 | 1,610 | 2,394 |
Net Income to Common | 868 | 1,070 | 1,262 | 1,860 | 1,610 | 2,394 |
Net Income Growth | -25.81% | -15.21% | -32.15% | 15.53% | -32.75% | 8.92% |
Shares Outstanding (Basic) | 29 | 29 | 29 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 29 | 29 | 29 | 30 | 30 | 30 |
Shares Change | - | - | -2.80% | -0.36% | 0.03% | -0.47% |
EPS (Basic) | 29.70 | 36.61 | 43.18 | 61.86 | 53.35 | 79.35 |
EPS (Diluted) | 29.70 | 36.61 | 43.18 | 61.86 | 53.35 | 79.35 |
EPS Growth | -25.81% | -15.21% | -30.20% | 15.95% | -32.77% | 9.44% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -5,931 | 1,751 | 5,863 | 3,600 | 2,076 |
Free Cash Flow Per Share | - | -202.92 | 59.91 | 194.98 | 119.29 | 68.81 |
Dividend Per Share | 12.000 | 12.000 | 12.000 | 12.000 | 12.000 | 11.000 |
Dividend Growth | 0% | 0% | 0% | 0% | 9.09% | 10.00% |
Gross Margin | - | 40.66% | 41.45% | 41.54% | 41.92% | 41.64% |
Operating Margin | 2.23% | 2.51% | 2.58% | 3.32% | 2.89% | 3.61% |
Profit Margin | 0.65% | 0.81% | 1.03% | 1.61% | 1.47% | 2.24% |
Free Cash Flow Margin | - | -4.49% | 1.43% | 5.08% | 3.29% | 1.95% |
EBITDA | 6,417 | 6,731 | 6,568 | 6,996 | 6,121 | 6,708 |
EBITDA Margin | - | 5.09% | 5.37% | 6.06% | 5.59% | 6.29% |
D&A For EBITDA | 3,418 | 3,417 | 3,414 | 3,163 | 2,957 | 2,855 |
EBIT | 2,999 | 3,314 | 3,154 | 3,833 | 3,164 | 3,853 |
EBIT Margin | - | 2.51% | 2.58% | 3.32% | 2.89% | 3.61% |
Effective Tax Rate | - | 56.35% | 52.30% | 45.78% | 46.02% | 40.47% |